Mid Continent Capital’s Gilead Sciences GILD Stock Holding History

Mid Continent Capital’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	$570K	Buy	5,802 +1,100	+23%	+$122K	0.04%	191
2015 Q2	$551K	Sell	4,702 -152	-3%	-$16.6K	0.03%	222
2015 Q1	$476K	Buy	4,854 +950	+24%	+$96.5K	0.03%	234
2014 Q4	$368K	Sell	3,904 -2,700	-41%	-$279K	0.02%	241
2014 Q3	$703K	Sell	6,604 -2,000	-23%	-$196K	0.04%	198
2014 Q2	$713K	Sell	8,604 -3,750	-30%	-$292K	0.04%	201
2014 Q1	$875K	Sell	12,354 -6,250	-34%	-$490K	0.05%	188
2013 Q4	$1.4M	Buy	+18,604	New	+$1.3M	0.09%	151

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Mid Continent Capital's GILD Position: Q3 2015 in Review

Mid Continent Capital increased its Gilead Sciences (GILD) stake by 23% in Q3 2015, buying an estimated $122K and bringing the position to 5,802 shares worth $570K. The position accounts for 0.04% of the portfolio, ranked #191.

Mid Continent Capital first reported a position in GILD in Q4 2013 and has held it in 8 quarters since. The position peaked at $1.4M in Q4 2013. 1,573 funds tracked by Wall St. Rank hold GILD as of Q3 2015.

Mid Continent Capital held 5,802 shares of Gilead Sciences worth $570K as of Q3 2015.
Mid Continent Capital bought 1,100 Gilead Sciences shares in Q3 2015, an estimated $122K.
Gilead Sciences made up 0.04% of Mid Continent Capital's portfolio in Q3 2015, its #191 holding.
Mid Continent Capital first reported a position in Gilead Sciences in Q4 2013 and has held it in 8 quarters since.
Mid Continent Capital's Gilead Sciences position peaked at $1.4M in Q4 2013.
1,573 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2015.

Based on Mid Continent Capital's 13F filing for Q3 2015, filed 22 Oct 2015.